Breaking News: F.D.A. approves sickle cell treatments, including one that uses CRISPR

View in browser | nytimes.com   BREAKING NEWS The F.D.A. approved the first gene editing therapy ever, for sickle cell disease. This breakthrough offers hope, but also comes with obstacles. Friday, December 8, 2023 11:57 AM ET The agency also approved a second treatment using conventional gene therapy for sickle cell disease, a debilitating blood disorder caused by a single mutated gene. Read more   ADVERTISEMENT You received this email because you signed up for NYTimes.com's Breaking News Alerts. To stop receiving Breaking News Alerts, unsubscribe. To opt out of other promotional emails from the Times, manage your email preferences. Subscribe to the Times Get the NYT app Change Your Email Privacy Policy Contact Advertise California Notice The New York Times Company, 620 Eighth Avenue, New York, NY 10018